Table 2.
Bronchoalveolar lavage results.
| SARS-CoV-2 positive (n = 14) | SARS-CoV-2 negative (n = 41) | |
|---|---|---|
| Pathogens | ||
| SARS-CoV-2 | 13 (93%) | 0 |
| Other pathogens | 1 (7%) | 23 (56%)∗ |
| Bacteria | 1 (7%) | 14 (34%) |
| Streptococcus pneumoniae | 0 | 2 (5%) |
| Streptococcus constellatus | 0 | 1 (2%) |
| Haemophilus pneumoniae | 0 | 3 (7%) |
| Serratia marcescens | 1 (7%) | 0 |
| Escherichia coli | 0 | 2 (5%) |
| Acinetobacter baumanii | 0 | 1 (2%) |
| Prevotella sp. | 0 | 1 (2%) |
| Chlamydia pneumoniae | 0 | 2 (5%) |
| Mycoplasma pneumoniae | 0 | 1 (2%) |
| Pneumocystis jirovecii | 0 | 1 (2%) |
| Mycobacterium tuberculosis | 0 | 1 (2%) |
| Virus | 0 | 7 (17%) |
| Influenza A | 0 | 4 (10%) |
| Metapneumovirus | 0 | 1 (2%) |
| Adenovirus | 0 | 1 (2%) |
| Herpes simplex virus | 1 (2%) | |
| Fungi | 0 | 1 (2%) |
| Aspergillus fumigatus | 0 | 1 (2%)† |
| No pathogen | 0 | 18 (44%) |
| Outcome at 4 weeks after BAL | ||
| Death | 1 (7%) | 4 (10%) |
| ICU | 3 (21%)∗ | 0 |
| 6 (43%) | 0 | SARS-CoV-2-dedicated unit hospitalisation |
| 1 (7%) | 5 (12%) | Ward hospitalisation |
| Discharged | 3 (21%) | 32 (78%)∗ |
∗ p < 0.05 for comparisons between SARS-CoV-2-positive and negative patients. †Galactomannan value: 6. Abbreviations: BAL—bronchoalveolar lavage; ICU—intensive care unit.